Search by Drug Name or NDC
NDC 42227-0083-01 Cinryze Details
Cinryze
Cinryze is a KIT in the PLASMA DERIVATIVE category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is .
Product Information
NDC | 42227-0083 |
---|---|
Product ID | 42227-083_696969cf-1588-4eec-9874-7de096db04dd |
Associated GPIs | 85802022002120 |
GCN Sequence Number | 040429 |
GCN Sequence Number Description | C1 esterase inhibitor VIAL 500 (5 ML) INTRAVEN |
HIC3 | M0N |
HIC3 Description | C1 ESTERASE INHIBITORS |
GCN | 10495 |
HICL Sequence Number | 018568 |
HICL Sequence Number Description | C1 ESTERASE INHIBITOR |
Brand/Generic | Brand |
Proprietary Name | Cinryze |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | HUMAN C1-ESTERASE INHIBITOR |
Product Type | PLASMA DERIVATIVE |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA125267 |
Listing Certified Through | 2024-12-31 |
Package
NDC 42227-0083-01 (42227008301)
NDC Package Code | 42227-083-01 |
---|---|
Billing NDC | 42227008301 |
Package | 1 KIT in 1 CARTON (42227-083-01) * 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) * 5 mL in 1 VIAL, GLASS (64764-515-50) |
Marketing Start Date | 2021-01-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |